Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05497804
What this trial is testing

Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

Who this might be right for
ISS Stage III Plasma Cell MyelomaMultiple Myeloma
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT02506959
What this trial is testing

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasmacytomaRecurrent Plasma Cell Myeloma+1 more
M.D. Anderson Cancer Center 83
Testing effectiveness (Phase 2)Study completedNCT00784823
What this trial is testing

Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 32
Testing effectiveness (Phase 2)Study completedNCT00281476
What this trial is testing

The Effect of High Dose Simvastatine on Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 10
Post-approval studies (Phase 4)Study completedNCT06425276
What this trial is testing

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

Who this might be right for
Multiple Myeloma
CASI Pharmaceuticals (China) Co., Ltd. 67
Testing effectiveness (Phase 2)Study completedNCT00060255
What this trial is testing

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
Roswell Park Cancer Institute 451
Large-scale testing (Phase 3)Study completedNCT03301220
What this trial is testing

Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Janssen Research & Development, LLC 390
Testing effectiveness (Phase 2)Study completedNCT00007995
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Herbert Irving Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00482261
What this trial is testing

Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Who this might be right for
Multiple Myeloma
Peter MacCallum Cancer Centre, Australia 150
Large-scale testing (Phase 3)Active Not RecruitingNCT01208662
What this trial is testing

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Who this might be right for
Multiple Myeloma
Paul Richardson, MD 729
Testing effectiveness (Phase 2)Study completedNCT02217163
What this trial is testing

Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Singapore General Hospital 30
Very early researchActive Not RecruitingNCT02603887
What this trial is testing

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 20
Not applicableStudy completedNCT00536601
What this trial is testing

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more
Roswell Park Cancer Institute 174
Large-scale testing (Phase 3)UnknownNCT00571168
What this trial is testing

Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy

Who this might be right for
Multiple Myeloma
Heidelberg University 362
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Not applicableEnded earlyNCT01794572
What this trial is testing

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

Who this might be right for
Multiple Myeloma in Relapse
Institut Cancerologie de l'Ouest 13
Testing effectiveness (Phase 2)Ended earlyNCT02681302
What this trial is testing

Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence

Who this might be right for
Multiple MyelomaLymphoma
Hackensack Meridian Health 46
Early research (Phase 1)Study completedNCT00388999
What this trial is testing

Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Enzon Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)Looking for participantsNCT02727803
What this trial is testing

Personalized NK Cell Therapy in CBT

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia+23 more
M.D. Anderson Cancer Center 100
Next Page